ATE140001T1 - Isochromanderivate - Google Patents

Isochromanderivate

Info

Publication number
ATE140001T1
ATE140001T1 AT91201119T AT91201119T ATE140001T1 AT E140001 T1 ATE140001 T1 AT E140001T1 AT 91201119 T AT91201119 T AT 91201119T AT 91201119 T AT91201119 T AT 91201119T AT E140001 T1 ATE140001 T1 AT E140001T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
group
alkoxy
hydroxy
Prior art date
Application number
AT91201119T
Other languages
English (en)
Inventor
Jean-Claude Laigle
Michel Combourieu
Nadine Simbille
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE140001T1 publication Critical patent/ATE140001T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT91201119T 1990-05-25 1991-05-10 Isochromanderivate ATE140001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401407 1990-05-25

Publications (1)

Publication Number Publication Date
ATE140001T1 true ATE140001T1 (de) 1996-07-15

Family

ID=8205714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91201119T ATE140001T1 (de) 1990-05-25 1991-05-10 Isochromanderivate

Country Status (15)

Country Link
EP (1) EP0458387B1 (de)
JP (1) JPH04253970A (de)
KR (1) KR910020004A (de)
AT (1) ATE140001T1 (de)
AU (1) AU643277B2 (de)
CA (1) CA2042861A1 (de)
DE (1) DE69120603T2 (de)
DK (1) DK0458387T3 (de)
ES (1) ES2091283T3 (de)
FI (1) FI912400A (de)
GR (1) GR3021084T3 (de)
IE (1) IE73232B1 (de)
NZ (1) NZ238243A (de)
PT (1) PT97766B (de)
ZA (1) ZA913691B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176722A1 (en) * 1993-12-28 1995-07-06 Ruth E. Ten Brink Heterocyclic compounds for the treatment of cns and cardiovascular disorders
US6387897B1 (en) 1998-06-30 2002-05-14 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
US6951862B2 (en) 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US6492375B2 (en) 1998-06-30 2002-12-10 Neuromed Technologies, Inc. Partially saturated calcium channel blockers
US7186726B2 (en) 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
US6943168B2 (en) 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
CA2903746C (en) 2013-03-08 2022-08-23 Amy Hauck Newman Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
EP3256466B9 (de) * 2015-02-11 2022-07-27 Sunovion Pharmaceuticals Inc. 1-heterocyclyl-isochroman-verbindungen und analoga davon zur behandlung von erkrankungen des zentralnervensystems
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
EP0450689A1 (de) * 1990-04-02 1991-10-09 Akzo Nobel N.V. Isochromanderivate

Also Published As

Publication number Publication date
NZ238243A (en) 1992-12-23
PT97766A (pt) 1992-03-31
AU643277B2 (en) 1993-11-11
DE69120603T2 (de) 1997-01-02
FI912400A (fi) 1991-11-26
DK0458387T3 (da) 1996-10-21
EP0458387B1 (de) 1996-07-03
KR910020004A (ko) 1991-12-19
AU7733491A (en) 1991-11-28
FI912400A0 (fi) 1991-05-17
GR3021084T3 (en) 1996-12-31
CA2042861A1 (en) 1991-11-26
JPH04253970A (ja) 1992-09-09
PT97766B (pt) 1998-10-30
EP0458387A1 (de) 1991-11-27
IE73232B1 (en) 1997-05-21
ZA913691B (en) 1992-02-26
IE911589A1 (en) 1991-12-04
ES2091283T3 (es) 1996-11-01
DE69120603D1 (de) 1996-08-08

Similar Documents

Publication Publication Date Title
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
ATE140001T1 (de) Isochromanderivate
ES2043807T3 (es) Compuestos anticancer.
ATE143661T1 (de) Imidazonaphthyridinderivate
ATE96446T1 (de) Estramustin-ester.
ES2065994T3 (es) Beta-dicetonas substituidas.
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
ES2053896T3 (es) 4,5-diariltioimidazoles 2-substituidos antihipercolesterolesmicos.
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
ATE105565T1 (de) Pradimicinderivate.
FI903967A0 (fi) Nya imidazolderivat.
DE68911893D1 (de) Antagonisten von Leukotrien D4.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee